Alpha Profiles · Company Profile

Axogen, Inc.

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves.

https://registry.alpha.ac/companies/axogen-inc

Entity: Public listing published
Primary listing: NASDAQ: AXGN
Verification: Partially verified
Last reviewed: 2026-09-13T04:45:53.225961+00:00

Overview

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for tissue donation, thereby eliminating associated complications. For facilitating t

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

Erick DeVinney

Chief Innovation Officer

State: unconfirmed
Effective: From Apr 29, 2026
Confidence: 88%
Evidence: DEF 14A axgn-20260429.htmApr 29, 2026

Jens Kemp

Chief Marketing Officer

State: unconfirmed
Effective: From Apr 29, 2026
Confidence: 88%
Evidence: DEF 14A axgn-20260429.htmApr 29, 2026

Lindsey Hartley

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000805928-26-000057Apr 29, 2026

Marc Began

Executive Vice President and General Counsel

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000805928-26-000057Apr 29, 2026

Michael Dale

Chief Executive Officer and President

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0000805928-26-000057Apr 29, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.